Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems explores the development of novel therapeutics and diagnostics to improve pulmonary disease management, looking down to the nanoscale level for an efficient system of targeting and managing respiratory disease. The book examines numerous nanoparticle-based drug systems such as nanocrystals, dendrimers, polymeric micelles, protein-based, carbon nanotube, and liposomes that can offer advantages over traditional drug delivery systems. Starting with a brief introduction on different types of nanoparticles in respiratory disease conditions, the book then focuses on current trends in disease pathology that use different in vitro and in vivo models.The comprehensive resource is designed for those new to the field and to specialized scientists and researchers involved in pulmonary research and drug development.- Explores recent perspectives and challenges regarding the management and diagnosis of chronic respiratory diseases- Provides insights into how advanced drug delivery systems can be effectively formulated and delivered for the management of various pulmonary diseases- Includes the most recent information on diagnostic methods and treatment strategies using controlled drug delivery systems (including nanotechnology)

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.

No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.

Perlego offers two plans: Essential and Complete

Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.

Both plans are available with monthly, semester, or annual billing cycles.

We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.

Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.

Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.

Yes, you can access Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems by Kamal Dua,Philip M. Hansbro,Ridhima Wadhwa,Mehra Haghi,Lisa G. Pont,Kylie A. Williams in PDF and/or ePUB format, as well as other popular books in Tecnologia e ingegneria & Biotecnologia in medicina. We have over one million books available in our catalogue for you to explore.

Information

Publisher

Year

Print ISBN

eBook ISBN

Topic

Tecnologia e ingegneria

Subtopic

Biotecnologia in medicina

Cover image
Title page
Table of Contents
Copyright
Dedication
Contributors
Editors biography
Chapter 1: Chronic respiratory diseases: An introduction and need for novel drug delivery approaches
Chapter 2: Drug delivery of respiratory medicines in practice
Chapter 3: Advanced drug delivery systems for respiratory diseases
Chapter 4: Novel drug delivery systems and significance in respiratory diseases
Chapter 5: Use of biologics in the treatment of asthma, COPD, ACOS, and idiopathic pulmonary fibrosis
Chapter 6: Targeting biofilms in chronic respiratory infections using drug delivery systems
Chapter 7: Absorption enhancement of macromolecule-administered intrapulmonary
Chapter 8: In silico analysis of drug delivery in respiratory disease
Chapter 9: Concepts of nanotechnology in nanomedicine: From discovery to applications
Chapter 10: Advancement in translational respiratory research using nanotechnology
Chapter 11: Nanoparticle-based macromolecule drug delivery to lungs
Chapter 12: Formulation and role of polymeric and inorganic nanoparticles in respiratory diseases
Chapter 13: Inhalable hybrid nanocarriers for respiratory disorders
Chapter 14: Functionalized nanoparticles in pulmonary disease diagnosis
Chapter 15: Drug delivery system in pulmonary disease: Role of microparticles
Chapter 16: Microparticulate drug delivery systems for targeting respiratory diseases
Chapter 17: Porous particulate platforms for enhanced pulmonary delivery of bioactives
Chapter 18: Liposomes in the treatment of chronic respiratory conditions
Chapter 19: Theranostic drug delivery systems for targeted therapy of lung diseases
Chapter 20: Targeted polymeric micellar systems for respiratory diseases
Chapter 21: Hydrogels for pulmonary drug delivery
Chapter 22: Mucoadhesive drug delivery systems in respiratory diseases
Chapter 23: Targeting lung cancer using advanced drug delivery systems
Chapter 24: Plant-based drug delivery systems in respiratory diseases
Chapter 25: Role of essential oils in respiratory diseases through advanced and nanodrug delivery systems
Chapter 26: Pharmacokinetics and pharmacodynamics of the advanced drug delivery systems
Index

About this book

Frequently asked questions

Information

Table of contents